Stock Day Media
MIRA Pharmaceuticals, Inc. Discusses Potential of Revolutionary THC Analog Drug, MIRA1a, with The Stock Day Podcast
August 09, 2023
The Stock Day Podcast welcomed MIRA Pharmaceuticals, Inc.(Nasdaq:MIRA)(the Company), a pre-clinical-stage pharmaceutical development company developing a Novel synthetic THC analog. CEO of the Company, Erez Aminov, joined Stock Day host Kevin Davis foll
Phoenix, Arizona
Stock Day Media is the top source for Penny and Micro-Cap news in America. Our Mission is to provide transparency to publicly traded companies and inform the investors directly. Our reach in the stock market community gives Stock Day the ability to find n
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast